Form 4: Aptevo Therapeutics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Dirk Huebner, SVP, CMO of Aptevo Therapeutics Inc., reported multiple transactions in common stock on August 6, 2026.
Summary
- Option exercise/conversion: acquired 638 Common Stock on August 6, 2026; holds 638 after (Direct).
- Tax/exercise-price withholding: disposed of 156 Common Stock at $4.07 ($635) on August 6, 2026; holds 482 after (Direct).
- Option exercise/conversion: disposed of 638 Restricted Stock Unit on August 6, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Dirk Huebner — Officer (SVP, CMO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-06 | Option exercise/conversion | Common Stock | 638 | — | — | 638 |
| 2026-08-06 | Tax/exercise-price withholding | Common Stock | 156 | $4 | $635 | 482 |
| 2026-08-06 | Option exercise/conversion | Restricted Stock Unit | 638 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-06 | Option exercise/conversion (638 shares) |
| 2026-08-06 | Tax/exercise-price withholding (156 shares) |
| 2026-08-06 | Option exercise/conversion (638 shares) |
Keywords
insider transaction, Form 4, APVO, Aptevo Therapeutics Inc., neutral, Dirk Huebner
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.